Axsome Therapeutics (AXSM) Short Interest Ratio & Short Volume $91.93 -1.76 (-1.88%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Axsome Therapeutics Short Interest DataAxsome Therapeutics (AXSM) has a short interest of 6.62 million shares. This marks a 1.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.2, indicating that it would take 11.2 days of the average trading volume of 724,302 shares to cover all short positions.Current Short Interest6,620,000 sharesPrevious Short Interest6,520,000 sharesChange Vs. Previous Month+1.53%Dollar Volume Sold Short$560.12 millionShort Interest Ratio11.2 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares48,460,000 sharesPercentage of Shares Shorted13.66%Today's Trading Volume808,350 sharesAverage Trading Volume724,302 sharesToday's Volume Vs. Average112% Short Selling Axsome Therapeutics? Sign up to receive the latest short interest report for Axsome Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAXSM Short Interest Over TimeAXSM Days to Cover Over TimeAXSM Percentage of Float Shorted Over Time Axsome Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20246,620,000 shares $560.12 million +1.5%N/A11.2 $84.61 12/15/20246,520,000 shares $587.45 million -7.9%N/A13.4 $90.10 11/30/20247,080,000 shares $695.40 million -7.9%N/A15.4 $98.22 11/15/20247,690,000 shares $716.48 million +1.5%N/A16.1 $93.17 10/31/20247,580,000 shares $674.85 million +0.8%N/A18.4 $89.03 10/15/20247,520,000 shares $649.95 million -3.1%N/A17 $86.43 9/30/20247,760,000 shares $697.39 million +1.2%N/A16.1 $89.87 9/15/20247,670,000 shares $718.45 million +0.8%N/A14 $93.67 8/31/20247,610,000 shares $676.22 million -0.8%N/A11.9 $88.86 8/15/20247,670,000 shares $656.63 million -5.8%N/A11.8 $85.61 Get the Latest News and Ratings for AXSM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20248,140,000 shares $710.70 million -1.7%N/A12 $87.31 7/15/20248,280,000 shares $685.58 million -3.5%N/A12 $82.80 6/30/20248,580,000 shares $690.69 million -3.5%N/A12.6 $80.50 6/15/20248,890,000 shares $654.57 million +7.5%N/A13.4 $73.63 5/31/20248,270,000 shares $607.27 million +9.0%N/A12.2 $73.43 5/15/20247,590,000 shares $576.31 million -1.6%N/A11.4 $75.93 4/30/20247,710,000 shares $568.69 million -0.5%N/A10.5 $73.76 4/15/20247,750,000 shares $528.63 million +1.3%N/A10.7 $68.21 3/31/20247,650,000 shares $610.47 million +4.8%N/A10.4 $79.80 3/15/20247,300,000 shares $551.44 million -2.3%N/A9.4 $75.54 2/29/20247,470,000 shares $607.91 million -0.7%N/A10.2 $81.38 2/15/20247,520,000 shares $702.82 million +0.4%N/A10.9 $93.46 1/31/20247,490,000 shares $674.32 million -10.0%N/A11.5 $90.03 1/15/20248,320,000 shares $708.95 million -1.2%N/A11.9 $85.21 12/31/20238,420,000 shares $670.15 million +0.7%N/A12.4 $79.59 12/15/20238,360,000 shares $610.20 million -1.1%N/A12.6 $72.99 11/30/20238,450,000 shares $569.95 million +10.6%N/A12.3 $67.45 11/15/20237,640,000 shares $460.00 million +4.0%N/A11.5 $60.21 10/31/20237,350,000 shares $457.76 million -3.2%N/A11 $62.28 10/15/20237,590,000 shares $504.51 million +1.6%N/A10.9 $66.47 9/30/20237,470,000 shares $522.08 million -8.0%N/A10.4 $69.89 9/15/20238,120,000 shares $611.11 million -1.5%N/A9.6 $75.26 8/31/20238,240,000 shares $665.79 million -3.5%N/A9.3 $80.80 8/15/20238,540,000 shares $609.41 million -5.7%N/A9.4 $71.36 7/31/20239,060,000 shares $710.94 million -2.6%N/A9.6 $78.47 7/15/20239,300,000 shares $684.76 million +1.8%N/A10.5 $73.63 6/30/20239,140,000 shares $656.80 million +17.8%24.5%10.1 $71.86 6/15/20237,760,000 shares $656.73 million +0.3%22.2%9.9 $84.63 5/31/20237,740,000 shares $571.06 million +0.9%22.2%9.9 $73.78 5/15/20237,670,000 shares $596.50 million -4.0%22.0%9.1 $77.77Must-See: 5-Second Trump Prediction (Ad)President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.Click here now to get the details because you must act before January 20th. 4/30/20237,990,000 shares $571.52 million +1.9%23.3%8.9 $71.53 4/15/20237,840,000 shares $537.04 million -4.5%22.8%8.6 $68.50 3/31/20238,210,000 shares $506.39 million -3.8%23.9%8.7 $61.68 3/15/20238,530,000 shares $528.26 million +1.6%24.8%8.9 $61.93 2/28/20238,400,000 shares $572.80 million +4.4%24.5%8.5 $68.19 2/15/20238,050,000 shares $508.28 million +5.4%23.5%6.9 $63.14 1/31/20237,640,000 shares $573 million -3.8%21.6%6.2 $75.00 1/15/20237,940,000 shares $534.36 million +5.2%22.4%5.9 $67.30 12/30/20227,550,000 shares $582.33 million +2.4%21.3%5.4 $77.13 12/15/20227,370,000 shares $570.88 million -7.1%20.8%5.1 $77.46 11/30/20227,930,000 shares $573.26 million +16.8%22.8%5.3 $72.29 11/15/20226,790,000 shares $372.91 million +9.0%19.5%5.2 $54.92 10/31/20226,230,000 shares $281.28 million +8.5%19.3%3.6 $45.15 10/15/20225,740,000 shares $275.52 million +2.5%17.8%3.7 $48.00 9/30/20225,600,000 shares $249.87 million -1.8%17.4%3.8 $44.62 9/15/20225,700,000 shares $351.63 million -3.7%17.7%2.9 $61.69 8/31/20225,920,000 shares $377.70 million +8.4%18.5%3.1 $63.80 8/15/20225,460,000 shares $258.64 million -5.0%17.1%3 $47.37 7/31/20225,750,000 shares $221.89 million -3.9%18.7%4.2 $38.59 7/15/20225,980,000 shares $261.27 million +7.4%19.5%4.1 $43.69 6/30/20225,570,000 shares $213.33 million +6.5%18.1%3.4 $38.30 6/15/20225,230,000 shares $120.29 million +4.8%17.0%3.6 $23.00 5/31/20224,990,000 shares $124.75 million +2.5%16.3%4.7 $25.00 5/15/20224,870,000 shares $135.87 million +7.7%15.9%4.6 $27.90 4/30/20224,520,000 shares $143.51 million -0.9%14.8%4.3 $31.75 4/15/20224,560,000 shares $168.08 million -4.6%15.0%4.7 $36.86 3/31/20224,780,000 shares $197.84 million +5.8%15.9%6.6 $41.39 3/15/20224,520,000 shares $131.67 million +2.3%15.0%7 $29.13 2/28/20224,420,000 shares $124.25 million +17.6%14.7%7.1 $28.11 2/15/20223,760,000 shares $126.90 million +8.4%12.7%6.3 $33.75 1/31/20223,470,000 shares $95.22 million +4.2%11.8%5.5 $27.44 1/15/20223,330,000 shares $95.24 million -2.9%11.3%5.5 $28.60 12/31/20213,430,000 shares $129.59 million -5.0%11.6%5.4 $37.78 12/15/20213,610,000 shares $118.30 million +2.9%12.2%5 $32.77 11/30/20213,510,000 shares $121.24 million +7.7%11.9%4.2 $34.54 11/15/20213,260,000 shares $125.44 million -2.1%11.0%3.5 $38.48 10/29/20213,330,000 shares $128.21 million -11.4%11.2%2.5 $38.50 10/15/20213,760,000 shares $150.78 million -0.3%12.7%2.6 $40.10 9/30/20213,770,000 shares $124.26 million +12.5%12.7%2.8 $32.96 9/15/20213,350,000 shares $92.86 million -16.5%11.3%2.7 $27.72 8/31/20214,010,000 shares $102.98 million +17.9%13.5%3.5 $25.68 8/13/20213,400,000 shares $77.72 million +15.3%11.5%3.4 $22.86 7/30/20212,950,000 shares $143.34 million +8.5%10.0%4.8 $48.59 7/15/20212,720,000 shares $154.41 million -6.2%9.2%6.9 $56.77 6/30/20212,900,000 shares $195.63 million -12.9%9.8%7.7 $67.46 6/15/20213,330,000 shares $223.81 million -2.1%11.3%8.9 $67.21 5/28/20213,400,000 shares $206.41 million +4.3%11.5%9.2 $60.71 5/14/20213,260,000 shares $195.70 million +5.2%11.0%8.9 $60.03 4/30/20213,100,000 shares $191.52 million +7.3%10.5%8.7 $61.78 4/15/20212,890,000 shares $154.76 million -0.3%9.8%8.7 $53.55Must-See: 5-Second Trump Prediction (Ad)President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.Click here now to get the details because you must act before January 20th. 3/31/20212,900,000 shares $162.14 million -8.5%9.9%9.7 $55.91 3/15/20213,170,000 shares $210.77 million -1.3%10.8%10.2 $66.49 2/26/20213,210,000 shares $219.50 million +4.2%10.9%10.2 $68.38 2/12/20213,080,000 shares $227.00 million -8.6%10.5%10 $73.70 1/29/20213,370,000 shares $235.36 million +0.6%11.5%10.7 $69.84 1/15/20213,350,000 shares $267.63 million -3.2%11.4%10.7 $79.89 12/31/20203,460,000 shares $288.08 million +2.4%11.8%11.4 $83.26 12/15/20203,380,000 shares $270.23 million +1.2%11.5%10.7 $79.95 11/30/20203,340,000 shares $251.10 million -3.5%11.4%9.3 $75.18 11/15/20203,460,000 shares $256.66 million +0.3%11.8%9.5 $74.18 10/30/20203,450,000 shares $234.70 million -4.7%11.8%9.3 $68.03 10/15/20203,620,000 shares $270.16 million -5.2%12.4%9.4 $74.63 9/30/20203,820,000 shares $272.18 million +4.1%13.1%9.4 $71.25 9/15/20203,670,000 shares $298.22 million -4.4%12.6%7.8 $81.26 8/31/20203,840,000 shares $281.51 million -1.0%13.1%8.4 $73.31 8/14/20203,880,000 shares $306.52 million +0.3%13.3%8.1 $79.00 7/31/20203,870,000 shares $276.05 million No Change13.5%7.3 $71.33 7/15/20203,870,000 shares $307.36 million +0.3%13.5%5.7 $79.42 6/30/20203,860,000 shares $317.60 million +9.0%13.4%5.1 $82.28 6/15/20203,540,000 shares $255.84 million +4.1%12.3%4.3 $72.27 5/29/20203,400,000 shares $261.73 million -0.9%11.8%3.5 $76.98 5/15/20203,430,000 shares $298.00 million -4.5%11.9%3.4 $86.88 4/30/20203,590,000 shares $341.16 million -14.9%12.5%3.6 $95.03 4/15/20204,220,000 shares $271.89 million +8.5%14.6%4.8 $64.43 3/31/20203,890,000 shares $297.20 million -6.5%13.5%4.4 $76.40 3/13/20204,158,800 shares $233.52 million +10.0%20.1%5.5 $56.15 2/28/20203,780,000 shares $241.58 million -4.1%18.2%3.3 $63.91 2/14/20203,940,000 shares $305.39 million -3.0%13.8%3.2 $77.51 1/31/20204,060,000 shares $340.31 million +1.8%14.2%3.1 $83.82 AXSM Short Interest - Frequently Asked Questions What is Axsome Therapeutics' current short interest? Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 6,620,000 shares of AXSM short. Learn More on Axsome Therapeutics' current short interest. What is a good short interest ratio for Axsome Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXSM shares currently have a short interest ratio of 11.0. Learn More on Axsome Therapeutics's short interest ratio. Which institutional investors are shorting Axsome Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Axsome Therapeutics: Jane Street Group LLC, Wolverine Trading LLC, Point72 Asset Management L.P., Walleye Trading LLC, Walleye Capital LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Axsome Therapeutics' short interest increasing or decreasing? Axsome Therapeutics saw a increase in short interest in December. As of December 31st, there was short interest totaling 6,620,000 shares, an increase of 1.5% from the previous total of 6,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Axsome Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Axsome Therapeutics: Genmab A/S (0.22%), Viatris Inc. (2.96%), Intra-Cellular Therapies, Inc. (1.87%), Summit Therapeutics Inc. (2.70%), Moderna, Inc. (11.03%), Dr. Reddy's Laboratories Limited (1.57%), Catalent, Inc. (8.12%), Sarepta Therapeutics, Inc. (5.37%), Qiagen (1.38%), Vaxcyte, Inc. (11.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Axsome Therapeutics stock? Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. AXSM shares are trading down $1.76 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Axsome Therapeutics? A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further. How often is Axsome Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Genmab A/S Short Interest Viatris Short Interest Intra-Cellular Therapies Short Interest Summit Therapeutics Short Interest Moderna Short Interest Dr. Reddy's Laboratories Short Interest Catalent Short Interest Sarepta Therapeutics Short Interest Qiagen Short Interest Vaxcyte Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXSM) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
